Evandro de Azambuja: Diversity in Clinical Trials
Evandro de Azambuja, President of the Belgian Society of Medical Oncology (BSMO) for 2023-2026, shared a post on LinkedIn about a paper he co-authored with colleagues published in Clinical Breast Cancer:
“Diversity in clinical trials: our analysis shows that despite the younger age and more aggressive BC, survival outcomes in patients of Maghreb vs. non-Maghreb origin did not differ. These results underscore the importance of considering ethnic minority populations to develop tailored prevention strategies and improve their inclusion in clinical trials.”
Title: Characteristics, treatment patterns and clinical outcomes of women with Maghreb origin and diagnosis of breast cancer: a single-center, retrospective cohort study
Authors: Chiara Dauccia, Diogo Martins-Branco, Michel Moreau, Lieveke Ameye, Elisa Agostinetto, Luca Arecco, Soraia Lobo-Martins, Anja Skoporc, Isabel Vilas-Boas, Masa Auprih, Ahmad Awada, Véronique Debien, Evandro de Azambuja
You can read the Full Article in Clinical Breast Cancer.
More posts featuring Evandro de Azambuja.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023